TP53INP1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.728760E-01 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.497800E-01 |
Normal-vs-Stage2 |
3.686800E-01 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
6.126000E-01 |
Stage1-vs-Stage2 |
6.304600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.532600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.840200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.008600E-01 |
Normal-vs-AfricanAmerican |
1.463360E-03 |
Normal-vs-Asian |
3.603600E-01 |
Caucasian-vs-AfricanAmerican |
2.624600E-01 |
Caucasian-vs-Asian |
9.948200E-01 |
AfricanAmerican-vs-Asian |
1.010650E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.413800E-01 |
Normal-vs-Female |
2.708200E-01 |
Male-vs-Female |
9.153800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.582800E-01 |
Normal-vs-Extreme_Weight |
1.866610E-01 |
Normal-vs-Obese |
4.431400E-01 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.495600E-01 |
Normal_Weight-vs-Obese |
9.952800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.554400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.089200E-01 |
Normal-vs-Age(41-60Yrs) |
4.006800E-01 |
Normal-vs-Age(61-80Yrs) |
4.425600E-01 |
Normal-vs-Age(81-100Yrs) |
2.425900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.322000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.039000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.064050E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.649600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.272180E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.136170E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.026800E-01 |
Normal-vs-Grade 3 |
9.735000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.379600E-01 |
Grade 2-vs-Grade 4 |
8.026800E-01 |
Grade 3-vs-Grade 4 |
9.735000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.473560E-01 |
Normal-vs-N1 |
5.252000E-01 |
N0-vs-N1 |
3.427000E-01 |
|
|